Recent Finacing
Recent Raise
Neurana Pharmaceuticals in San Diego develops a tolperisone formulation licensed from Sanochemia to meet ICH impurity limits and is initiating Phase 2 dose‑ranging trials for acute neck/back muscle spasms.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Neurana Pharmaceuticals.
